Series C - Abbisko Therapeutics - Mar 25, 2020 Funding Round Profile - Cointime

Bitcoin $98,848.24 -0.01%
Ethereum $3,352.74 -0.43%
BNB $649.88 +3.16%
Optimism $2.20 +7.29%
Arbitrum $0.82 +5.14%
Solana $259.54 +0.16%
Polygon $0.54 +16.85%
Cosmos $7.88 +19.31%
Avalanche $43.68 +20.96%

Bitcoin $98,848.24 -0.01%
Ethereum $3,352.74 -0.43%
BNB $649.88 +3.16%
Optimism $2.20 +7.29%
Arbitrum $0.82 +5.14%
Solana $259.54 +0.16%
Polygon $0.54 +16.85%
Cosmos $7.88 +19.31%
Avalanche $43.68 +20.96%

Abbisko Therapeutics

company

Funding Round

Series C

Money Raised

$ 70M

Propotion

-

Post Valuation

-

Current Round Investors

Investor Name	Invest Money	Lead Investor	Propotion
Lilly Asia Ventures	-	-	-	Detail

Historical Financing

Announced Date	Round	Money Raised	Investors
Feb 7, 2017	Series A	$ 28M	Lilly Asia Ventures	Detail
Mar 21, 2019	Series B	$ 42M	Lilly Asia Ventures	Detail